In the Lab
By Julie Grisham, MS, Science Writer/Editor | Thursday, January 3, 2013
A team from Memorial Sloan Kettering has found that the makeup of immune cells in a lung tumor and in tissue surrounding a tumor can predict whether the cancer will recur after surgery.
In the Clinic
By Jim Stallard, MA, Writer/Editor | Friday, November 9, 2012
A genetic analysis of tumors suggests women are more susceptible than men to the most common form of lung cancer.
By Memorial Sloan Kettering | Wednesday, October 31, 2012
Dr. Huang discusses how minimally invasive, video-assisted, and robotic surgical techniques improve the treatment of patients with lung, esophageal, and thyroid cancers.
By Jim Stallard, MA and Julie Grisham, MS
Friday, September 21, 2012
With the genomics revolution, scientists and physicians have increasingly been able to peer at the inner workings of tumor cells and pinpoint the specific genetic changes that transform them from their cells of origin into cancer.
By Memorial Sloan Kettering | Wednesday, September 19, 2012
Memorial Sloan Kettering researchers have discovered a way that cancer cells may be able to exchange information by establishing long bridges between cells called tunneling nanotubes.
By Memorial Sloan Kettering | Tuesday, August 28, 2012
Dr. Finley, Co-Director of the Complex Airway Program, explains how he lays out a treatment plan with his patients, and determines which type of surgery fits best in the context of their lifestyle.
By Memorial Sloan Kettering | Wednesday, July 25, 2012
Thoracic surgeon Inderpal Sarkaria discusses the expertise of Memorial Sloan Kettering surgeons at performing complex operations to treat cancers of the lung, esophagus, and chest wall.
By Memorial Sloan Kettering | Friday, June 15, 2012
Dr. Bains talks about how he and other internationally recognized cancer experts work together to treat patients and help them return to their everyday activities.
By Memorial Sloan Kettering | Wednesday, June 6, 2012
In our recently updated guides to non-small cell and small-cell lung cancers, you can learn about diagnosis, treatment, follow-up care, lung cancer experts, and clinical trials at Memorial Sloan Kettering.
By Allyson Collins, MS, Science Writer/Editor | Monday, May 21, 2012
In an interview, Dr. Bach talks about research showing that CT screening may prevent one in five cancer deaths for people at a very high risk of developing lung cancer.
By Media Staff | Thursday, May 17, 2012
Memorial Sloan Kettering was one of the first centers to use this type of genetic testing for lung cancer patients and is currently one of the only centers testing for mutations in squamous cell carcinomas of the lung.
By Memorial Sloan Kettering | Thursday, May 3, 2012
Dr. Rusch, Chief of the Thoracic Service, discusses the multidisciplinary care plan that is developed for each patient by a specialized team of physicians at Memorial Sloan Kettering.
By Memorial Sloan Kettering | Monday, December 5, 2011
Congratulations to Mark Kris, Chief of the Thoracic Oncology Service, and Ann Culkin, nurse on the Thoracic Oncology Service, for receiving the Wholeness of Life Award 2011 from the HealthCare Chaplaincy.
In the News
By Media Staff | Wednesday, November 23, 2011
Chief of Thoracic Oncology Mark Kris offers his perspective on a promising new tactic for treating lung and other cancers in this story from CBS Evening News with Scott Pelley. The strategy tailors cancer treatment to each individual patient.